Elective Hip Replacement

Also known as: Elective hip replacement surgery / Elective major hip replacement surgery

Drug	Drug Name	Drug Description
DB06695	Dabigatran etexilate	An anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation.

Drug	Drug Name	Target	Type
DB06695	Dabigatran etexilate	Prothrombin	target
DB06695	Dabigatran etexilate	P-glycoprotein 1	transporter
DB06695	Dabigatran etexilate	Liver carboxylesterase 1	enzyme
DB06695	Dabigatran etexilate	Cocaine esterase	enzyme
DB06695	Dabigatran etexilate	UDP-glucuronosyltransferase 1-9	enzyme
DB06695	Dabigatran etexilate	UDP-glucuronosyltransferase 2B7	enzyme
DB06695	Dabigatran etexilate	UDP-glucuronosyltransferase 2B15	enzyme
DB06695	Dabigatran etexilate	Ribosyldihydronicotinamide dehydrogenase [quinone]	enzyme
DB06695	Dabigatran etexilate	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count
DB00624	Testosterone	3	Completed	1